OAG 026 – April 2020 Related Content
Professor Mike Barnes: The future of medical cannabis is real
We spoke to Professor Mike Barnes, to discuss the future of medical cannabis and cut through the fake news saturating the field.
Obesity in Europe: An urgent and relevant health priority for policymakers
Jacqueline Bowman-Busato, EU Policy Lead at the European Association for the Study of Obesity, explains why obesity in Europe is an urgent and relevant health priority for policymakers, NGOs, research funders, health professionals and the public.
Carbalyst: Sustainable production of low carbon and renewable fuels
Carl De Maré discusses how Carbalyst produce low carbon and renewable fuels through fermenting industrial process gasses from the iron and steel industry.
HYDROUSA: Water loops with regenerative business models for the Mediterranean
Here, Simos Malamis explains the HYDROUSA project, which seeks to innovate wastewater treatment and create regenerative business models in the Mediterranean region.
The potential of new mobility services: E-scooter, ride-hailing & autonomous driving
Kristina Stifter, Head of Global Communications at PTV Group, explains e-scooter, ride-hailing and autonomous driving plus how studies show the potential of new mobility services.
Robotics: The story of a multi-robot café with PRINTEPS
Here, Takahira Yamaguchi from Keio University in Japan explores how different robots cooperate in a multi-robot café, beginning with details about service workflow.
The built environment: The effects of office conversions in the Netherlands
Sophie Hoogendijk and Gideon Bolt from the Faculty of Geosciences – Utrecht University, describe the effects of office conversions in the Netherlands, commencing with commentary on vacant offices in this analysis of the built environment.
The case for coaching supervision: How does a coach self-care?
Karen Dean and Sam Humphrey state the case for coaching supervision including how a coach utilises self-care.
Climate Service Center Germany (GERICS) works to improve urban climate modelling capabilities
Here, GERICS discusses how they are engaging with stakeholders to improve urban climate modelling capabilities and fight climate change.
Cannabinoids in medicine part 4: Epilepsy
In the fourth of a series of five articles, Oxford Cannabinoid Technologies discuss their expertise on cannabinoids in medicine.
Malta’s stance on cannabis for medicinal and research purposes
Here, the Malta Medicines Authority (MMA) shares a vision which integrates regulatory sciences, innovation, and academic initiatives.
Rockford Associates: Accounts Payable Review aids Public Sector Finance
Here, Rockford Associates explain their experiences of recovery audit work and case study results.
Heart and vascular health research: A focus on cardiovascular sciences
David Goff, MD, PhD, Director, Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute at the National Institutes of Health in the U.S., introduces the work of the organisation and his thoughts on supporting heart and vascular health research.
The ethics of AI development in public policy
Dr Emma Carmel illustrates the paradoxical realities of ethics in AI development, with recommendations for forming an effective public policy.
Setting global standards for CBD quality and compliance
At Mile High Labs, we share a collective vision for global standards of CBD quality and compliance: Let’s discuss the Novel Food application process for the UK.
Digital transformation in Japan and the European Union
Agnieszka Kuczynska from AGH University of Science and Technology charts the prominence of digital transformation in Japan and the European Union today.
Technology focus: Fujitsu scanners in the public sector
Robyn Boyd on behalf of PFU (EMEA) Limited – a Fujitsu company turns our thoughts to the extent to which technology is heavily relied upon in the public sector, focussing specifically on the role of Fujitsu scanners in this vein.
Accelerating transitions for a Green Deal: Preparing a recovery after the pandemic
Here, Prof Dr Raimund Bleischwitz discusses the overlaps between transitioning to a Green Deal and preparing for recovery after the pandemic.
The FDA’s 2020 Cannabis policy
Here, Ann Allworth discusses what lies ahead for the FDA’s 2020 Cannabis policy and highlights discrepancies in their thinking.
Think Tank highlights CROs key role in optimising innovation pathways
Prof Dr Freimut Schliess, Director of Profil GmbH, discusses how CROs can play a key role for the optimisation of innovation pathways.